R. Sandner

Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study

J. Radford, A. Santoro, S. Ansell, 2021, Targeted Oncology.

Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis

S. Park, N. Tsuchiya, Jae-Lyun Lee, 2022, International Journal of Clinical Oncology.